Loading…
GE HealthCare Technologies Inc. is projected to rise to $72.96 by 2027, a +14% move from its current price of $63.88. GEHC is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $62.83 | $63.90 | $64.98 | +0.03% |
| May 30 | $62.41 | $63.92 | $65.46 | +0.06% |
| May 31 | $62.10 | $63.94 | $65.83 | +0.09% |
| Jun 1 | $61.84 | $63.95 | $66.14 | +0.12% |
| Jun 2 | $61.61 | $63.97 | $66.43 | +0.15% |
| Jun 3 | $61.41 | $63.99 | $66.69 | +0.18% |
| Jun 4 | $61.22 | $64.01 | $66.93 | +0.21% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $61.22 | $64.01 | $66.93 | +0.21% |
| Week 2 | $60.23 | $64.14 | $68.31 | +0.41% |
| Week 3 | $59.50 | $64.27 | $69.43 | +0.62% |
| Week 4 | $58.92 | $64.41 | $70.40 | +0.82% |
| Week 5 | $58.42 | $64.54 | $71.29 | +1.03% |
| Week 6 | $57.99 | $64.67 | $72.12 | +1.24% |
| Week 7 | $57.60 | $64.80 | $72.90 | +1.45% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
GE HealthCare Technologies Inc. is a healthcare company that develops, manufactures, and markets products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. It operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx).
The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women’s health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases. The PCS segment provides medical devices, consumables, services, and digital solutions, with a portfolio that includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products.
The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography, plus contrast media pharmaceuticals and radiopharmaceuticals. The company has a strategic collaboration with DeepHealth. GE HealthCare Technologies Inc.
was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
GE HealthCare Technologies Inc. (GEHC) is currently priced at $64.23 per share, with a market capitalization of $29.22B and a rank of 453. These figures position the company among healthcare peers with a substantial market footprint.
A major floor 20.4% below — a decisive break under it would weaken the trend.
The nearest floor, 6.9% below — buyers have tended to step in here.
The nearest ceiling, 16.9% above — a clean break opens room to run.
A major ceiling 31.9% above — clearing it would confirm fresh momentum.
Key GEHC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of GEHC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $64.18 | Sell | $63.77 | Buy |
| MA 10 | $62.93 | Buy | $63.40 | Buy |
| MA 20 | $62.16 | Buy | $63.99 | Sell |
| MA 50 | $67.78 | Sell | $67.55 | Sell |
| MA 100 | $74.21 | Sell | $71.28 | Sell |
| MA 200 | $75.47 | Sell | $74.05 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 46.38 | Neutral |
| Stoch RSI (14) | 90.84 | Sell |
| CCI (20) | 95.33 | Neutral |
| Williams %R (14) | -12.61 | Info |
| MACD (12,26,9) | 0.66 | Buy |
| ROC (12) | 0.65 | Buy |
| Bollinger %B (20,2) | 0.81 | Neutral |
| Stochastic %K (14) | 87.39 | Sell |
| TRIX (15) | -0.44 | Sell |
| Awesome (5,34) | -2.14 | Sell |
| Ultimate (7,14,28) | 72.79 | Sell |
| Momentum (10) | 1.59 | Buy |
| Aroon Osc (25) | -24.00 | Sell |
| Hull MA (9) | 64.84 | Sell |
| ADX (14) | 19.18 | Neutral |
| ATR (14) | 0.98 | Info |
The near-term technical picture shows a neutral stance, with RSI14 at 50. The stock trades with SMA50 at $68.08 and SMA200 at $75.55. The 30-day price range runs from a low of $57.09 to a high of $72.26. Support is at $59.49 and resistance at $74.67, framing a modest scope for price movement in the short run.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $59.49 | $63.88 | $83.70 | 0% | Neutral | |
| $59.60 | $72.96 | $93.48 | +14% | Neutral | |
| $70.10 | $87.38 | $114.89 | +37% | Bullish | |
| $77.04 | $97.48 | $130.83 | +53% | Bullish | |
| $85.39 | $109.48 | $149.54 | +71% | Bullish | |
| $88.47 | $114.81 | $159.25 | +80% | Bullish | |
| $86.57 | $113.59 | $159.78 | +78% | Bullish | |
| $95.45 | $126.56 | $180.31 | +98% | Bullish | |
| $99.74 | $133.55 | $192.52 | +109% | Bullish | |
| $107.33 | $145.07 | $211.44 | +127% | Bullish | |
| $139.68 | $196.88 | $300.62 | +208% | Bullish | |
| $272.38 | $411.67 | $673.61 | +544% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $59.49 | $63.88 | $74.59 | +0.00% |
| June 2026 | $55.18 | $64.37 | $76.54 | +0.76% |
| July 2026 | $55.92 | $65.61 | $78.76 | +1.93% |
| August 2026 | $55.22 | $65.08 | $78.69 | -0.81% |
| September 2026 | $55.35 | $65.47 | $79.64 | +0.60% |
| October 2026 | $57.20 | $67.90 | $83.03 | +3.71% |
| November 2026 | $57.74 | $68.74 | $84.45 | +1.23% |
| December 2026 | $56.80 | $67.82 | $83.70 | -1.33% |
Click any year to see its month-by-month GEHC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect GEHC to range from $59.49 to $83.70 through 2026. The $63.88 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The GEHC price prediction for 2027 points to an average of $72.96 (low $59.60, high $93.48) — a potential gain of +14% on today's $63.88. A consolidation phase looks the most probable path here.
In 2028, GEHC is projected to trade between $70.10 and $114.89, averaging $87.38 — a potential gain of +37% from today's $63.88. That is up +20% on the projected 2027 average. Momentum favours further upside here.
GE HealthCare Technologies Inc.'s 2029 outlook centres on $97.48, within a $77.04 to $130.83 range. That is up +12% on the projected 2028 average. That marks a +53% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, GEHC could reach as high as $149.54, with a base case around $109.48 and support toward $85.39 — roughly +71% from $63.88. Momentum favours further upside here.
Expect GEHC to range from $88.47 to $159.25 through 2031. The $114.81 average target implies a +80% move from current prices. That is up +5% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The GEHC price prediction for 2032 points to an average of $113.59 (low $86.57, high $159.78) — a potential gain of +78% on today's $63.88. Momentum favours further upside here.
In 2033, GEHC is projected to trade between $95.45 and $180.31, averaging $126.56 — a potential gain of +98% from today's $63.88. That is up +11% on the projected 2032 average. Buyers look set to stay in control over this stretch.
GE HealthCare Technologies Inc.'s 2034 outlook centres on $133.55, within a $99.74 to $192.52 range. That is up +6% on the projected 2033 average. That marks a +109% change versus current levels. Momentum favours further upside here.
By 2035, GEHC could reach as high as $211.44, with a base case around $145.07 and support toward $107.33 — roughly +127% from $63.88. Buyers look set to stay in control over this stretch.
Expect GEHC to range from $139.68 to $300.62 through 2040. The $196.88 average target implies a +208% move from current prices. That is up +36% on the projected 2035 average. Momentum favours further upside here.
The GEHC price prediction for 2050 points to an average of $411.67 (low $272.38, high $673.61) — a potential gain of +544% on today's $63.88. Buyers look set to stay in control over this stretch.
Investing $1,000 in GEHC today (≈ 15.654352 GEHC) could be worth
$6,444.49
+$5,444.49 (+544%) by 2050 · US Dollar
Based on the average projected GEHC price of $411.67 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in GEHCwould be worth at today's price.
$1,000 invested in GEHC on May 27, 2025 (≈ 14.082523 GEHC) would be worth
$899.59
-$100.41 (-10.0%) today · 0.90× · US Dollar
Based on a GEHC entry price of $71.01 vs. today's $63.88.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $64.26 | $994.09 | -0.6% |
| 1 month ago | $70.48 | $906.36 | -9.4% |
| 3 months ago | $83.92 | $761.2 | -23.9% |
| 6 months ago | $79.99 | $798.6 | -20.1% |
| 1 year ago | $71.01 | $899.59 | -10.0% |
| All time (3.4y) ago | $60 | $1,064.67 | +6.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our GEHC forecast.
Our base-case forecast reaches $130.00 around 2034.
Implied market cap at $130.00: $59.14B
The multi-year forecast paints a bullish trajectory from 2028 onward, with the average price and ROI rising through 2030, 2040, and 2050. In 2026 the average is $64.23 with a 0% ROI and neutral sentiment, progressing to a 2027 average of $73.37 (14.2% ROI, neutral). By 2028 the average is $87.40 (36.1% ROI) and the outlook turns bullish, continuing to 2029 with an average of $97.50 (51.8% ROI) and 2030 with an average of $109.52 (70.5% ROI).
The forecast extends through 2031–2050, with 2031 at $114.17 (77.8% ROI), 2032 at $113.11 (76.1%), 2033 at $126.50 (97%), 2034 at $132.38 (106.1%), 2035 at $143.72 (123.8%), 2040 at $194.49 (202.8%), and 2050 at $406.57 (533%). The sentiment remains bullish from 2028 onward, reflecting an expanding long-run opportunity while acknowledging that these are estimates, not guarantees. Risks include market conditions and execution variability, which can affect realized outcomes.
Tap a question to reveal the answer.
In 2030, the forecast shows an average price of $109.52 with a min of $85.40 and a max of $149.62, and an ROI of 70.5%. The sentiment for 2030 is BULLISH.
The forecast indicates a bullish trajectory beginning in 2028 and extending through 2035–2050, with rising averages and ROIs (e.g., 2030 average $109.52 and 2035 max $209.50). These are forward-looking estimates and not guarantees.
The forecast shows a max of $209.50 in 2035, indicating a potential to exceed $200 based on the projected path.
Current price: $64.23. Market cap: $29.22B.
Near term, the RSI is 50 with neutral sentiment. The 30-day range is $57.09–$72.26, with support at $59.49 and resistance at $74.67. The SMA50 is $68.08 and the SMA200 is $75.55.
GE HealthCare Technologies Inc. Community Discussion
0Share your GE HealthCare Technologies Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.